Improving harm reduction services for drug use in rural areas
Promoting remote harm reduction and secondary services in rural settings (PROMOTE) study
This study is looking at how to improve support services for people in rural areas who are struggling with substance use, especially with opioids and methamphetamines, by finding better ways to deliver help remotely and making sure it's easy for everyone to access.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10590281 on NIH RePORTER |
What this research studies
This research investigates how to enhance harm reduction services for individuals dealing with substance use issues in rural communities. It focuses on understanding the changing patterns of drug use, particularly with opioids and methamphetamines, and the associated health risks like hepatitis C and HIV. The study aims to develop and evaluate remote delivery methods for these services, ensuring they are accessible even in areas with limited resources. By collaborating with harm reduction service providers and community members, the research seeks to tailor effective strategies that can be implemented in these settings.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals living in rural areas who are struggling with substance use, particularly those using opioids or methamphetamines.
Not a fit: Patients who do not reside in rural areas or those who do not engage in substance use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve health outcomes for individuals in rural areas affected by substance use disorders.
How similar studies have performed: Previous research has shown that harm reduction strategies can be effective in urban settings, but this approach in rural areas is relatively novel and untested.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Pho, Mai Tuyet — University of Chicago
- Study coordinator: Pho, Mai Tuyet
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.